Danish medical equipment company to introduce product on the US market
Medical Prognosis Institute expects to market diagnostic equipment for cancer patients at the end of the year. The newly appointed CEO of the company is a former Topotarget executive.
The relatively small Danish medical equipment company focused on diagnostics, Medical Prognosis Institute (MPI), could – if all goes well – be headed for the American market with two new products by the end of the year. The company’s core product, which has been under development for seven years, is a piece of diagnostic equipment aimed at cancer patients, a so-called Drug Response Predictor.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
